跳至主要内容
临床试验/CTRI/2023/05/052246
CTRI/2023/05/052246尚未招募2 期

A Prospective, Comparative, Open label Clinical Study to evaluate the Efficacy and Safety of Livvel Silk oil Soft gel Capsules in patients with Diabetes mellitus, Hypertension and Hyperlipidemia.

SEIDECOSAA Division of M/s INDIAN SILK FIBRE CO, India0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Subjects, aged 18 years and above.
  • Subjects diagnosed with Diabetes with hypertension and hyperlipidaemia, (newly diagnosed and patients who are on treatment).

排除标准

  • 1.Subjects presenting with any other life threatening co morbid disease conditions like renal failure, liver failure or severe heart failure.
  • 2.Participation in any other clinical study or test panel within the one month prior to entry into the study.
  • 3.History of allergy to test product
  • 4.History of HIV, HBV, Malignancy, alcohol or drug abuse.
  • 5.Pregnant or lactating subjects.

研究者

发起方
SEIDECOSAA Division of M/s INDIAN SILK FIBRE CO, India

相似试验